[The significance of amine oxidases in pathological states].
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism; D000818:Animals; D002384:Catalysis; D004194:Disease; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010084:Oxidation-Reduction; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000378:metabolism*; D011725:Pyridines / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000633:toxicity; D013379:Substrate Specificity
D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D006631:Amine Oxidase (Copper-Containing); D008995:Monoamine Oxidase; D000587:Oxidoreductases Acting on CH-NH Group Donors
Znachenie aminoksidaz pri patologicheskikh sostoianiiakh.